FDA Names Katherine Szarama Acting Director of Biologics Unit After Prasad Exit
The U.S. Food and Drug Administration has placed Katherine Szarama in the role of acting director for its Center for Biologics Evaluation and Research following the departure of Vinay Prasad. The center is responsible for oversight of vaccines, gene therapies and the nation’s blood supply. Commissioner Marty Makary has said a permanent replacement …